Changing incidence and delay of testicular cancer in southern Norway (1981-1992).
The medical records of 352 patients with newly diagnosed testicular cancer were reviewed.
Patients were orchiectomized during three 2-year periods (1981/82,1986/87,1991/92) and were referred for further treatment to the Norwegian Radium Hospital.
They represented 96% of all cases with unilateral testicular cancer occurring within a defined area in the southern part of Norway.
An increase in testicular cancer patients was registered, mainly between the second and third time periods (61% increase).
Gynaecomastia was recorded in 7% of all patients (seminoma : 6% ; non-seminoma : 8%). Serum tumour markers (alpha-fetoprotein and/or human choriogonadotropin) were elevated before orchiectomy in 51% of the evaluated patients.
During the studied 12-year period, considering seminoma and non-seminoma patients combined, the overall median delay decreased from 18 to 14 weeks (p=0.006), the overall median diagnostic delay decreased from 14 to 10 weeks (p=0.04) and the median treatment delay decreased from 37 to 28 days (p=0.002).
Due to increased frequency of stage I patients, introduction of an outpatient-based surveillance policy and improved administrative routines of the Health Care System, the median time of hospitalization was reduced from 37 (1981/82) to 9 days (1991/92).
In seminoma, but not in non-seminoma patients, an overall delay of less than 16 weeks from the onset of symptoms was correlated with the incidence of stage I disease. (...)
Mots-clés Pascal : Séminome, Testicule, Orchidectomie, Incidence, Gynécomastie, Norvège, Europe, Diagnostic, Traitement, Adulte, Homme, Mâle, Caucasoïde, Survie, Appareil génital mâle pathologie, Testicule pathologie, Tumeur maligne, Chirurgie, Epidémiologie, Glande mammaire pathologie
Mots-clés Pascal anglais : Seminoma, Testicle, Orchidectomy, Incidence, Gynecomasty, Norway, Europe, Diagnosis, Treatment, Adult, Human, Male, Caucasoid, Survival, Male genital diseases, Testicular diseases, Malignant tumor, Surgery, Epidemiology, Mammary gland diseases
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0492273
Code Inist : 002B20B02. Création : 10/04/1997.